CDC Funds COVID-19 Community Health Worker Initiative

Nov. 2, 2021
Program provides assistance to 68 states, localities, territories and tribal organizations

Community health workers are a key element of the public health response to the pandemic. They can help address the racial inequities that have left communities of color harder hit than others. In August 2021, the U.S. Centers for Disease Control and Prevention launched a Community Health Workers for COVID Response and Resilient Communities initiative.

The trusting relationships that community health workers build enable them to serve as a link between health/social services and the community to facilitate access to services and improve service delivery.

The CDC initiative, which is in its first year, will distribute a total of $348 million over three years. It provides financial support and technical assistance to 68 states, localities, territories, tribes, tribal organizations, urban Indian health organizations, and health service providers to tribes. It consists of two funding opportunities intended to put more trained community health workers in communities that have been hit hardest by COVID-19 and among populations at high risk for COVID-19 exposure, infection, and illness.

Intended communities are those with high rates of COVID-19 and long-standing health disparities related to race, income, geographic location, or other sociodemographic characteristics. Intended populations are those at high risk because of their race or ethnicity, income, incarceration, homelessness, or medical conditions.

The initiative has three components:

• Component A focuses on building capacity for community health worker (CHW) efforts among 32 organizations that have some experience with CHWs and want to build capacity by expanding training and oversight plans.

• Component B focuses on improving and expanding existing CHW efforts among 35 organizations with about three years of experience using CHWs.

• Component C focuses on developing innovative approaches within five organizations to strengthen the use of CHWs through policy, systems, or environmental changes.

Comprehensive work plans that are tailored by and for each community will guide CHW efforts. While the specifics of implementation will differ by area and funding, each community will use three key strategies, which together can help end the COVID-19 pandemic and move toward health equity:

• Train CHWs with the knowledge, roles, and skills to support the COVID-19 public health response to manage outbreaks and prevent community spread.

• Deploy CHWs to support the COVID-19 public health response to manage outbreaks and prevent the spread of COVID-19 among priority populations in communities.

• Engage CHWs to help build and strengthen community resilience to mitigate the impact of COVID-19 by improving the overall health of priority populations in communities.

Sponsored Recommendations

Data-driven, physician-focused approach to CDI improvement

Organizational profile Sisters of Charity of Leavenworth (SCL) Health* has been providing care since it originated in the 1600s in France as the Daughters of Charity. These religious...

Luminis Health improved quality and financial outcomes with advanced CDI technology and consulting from 3M

In the beginning, there were challengesBefore partnering with 3M Health Information Systems (HIS), Luminis Health’s clinical documentation integrity (CDI) program faced ...

Case Study: Intermountain Healthcare - AI-powered physician engagement to drive quality care

Health System profile Intermountain Healthcare is a Utah-based, nonprofit health system composed of 24 hospitals, 225 clinics, a medical group with 3,000 employed physicians and...

10 Reasons to Run Epic on Pure

Gain efficiency & add productivity to your Epic data center. Download now to learn more!

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1